|
1
|
Park JR, Eggert A and Caron H:
Neuroblastoma: Biology, prognosis, and treatment. Hematol Oncol
Clin North Am. 24:65–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
London WB, Castel V, Monclair T, Ambros
PF, Pearson AD, Cohn SL, Berthold F, Nakagawara A, Ladenstein RL,
Iehara T, et al: Clinical and biologic features predictive of
survival after relapse of neuroblastoma: A report from the
International Neuroblastoma Risk Group project. J Clin Oncol.
29:3286–3292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pearson AD, Pinkerton CR, Lewis IJ, Imeson
J, Ellershaw C and Machin D; European Neuroblastoma Study Group;
Children's Cancer and Leukaemia Group (CCLG formerly United Kingdom
Children's Cancer Study Group): High-dose rapid and standard
induction chemotherapy for patients aged over 1 year with stage 4
neuroblastoma: A randomised trial. Lancet Oncol. 9:247–256. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
London WB, Boni L, Simon T, Berthold F,
Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL and De
Bernardi B: The role of age in neuroblastoma risk stratification:
The German, Italian, and children's oncology group perspectives.
Cancer Lett. 228:257–266. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
6
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhen ZJ, Guo XF, Liao R, Yang KB, Ye LT
and You ZY: Involvement of IL-10 and TGF-β in HLA-E-mediated
neuroblastoma migration and invasion. Oncotarget. 7:44340–44349.
2016.PubMed/NCBI
|
|
8
|
Lynch J, Fay J, Meehan M, Bryan K, Watters
KM, Murphy DM and Stallings RL: MiRNA-335 suppresses neuroblastoma
cell invasiveness by direct targeting of multiple genes from the
non-canonical TGF-β signalling pathway. Carcinogenesis. 33:976–985.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Y, Sun J, Sheard MA, Tran HC, Wan Z,
Liu WY, Asgharzadeh S, Sposto R, Wu HW and Seeger RC: Lenalidomide
overcomes suppression of human natural killer cell anti-tumor
functions by neuroblastoma microenvironment-associated IL-6 and
TGFβ1. Cancer Immunol Immunother. 62:1637–1648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turley EA, Veiseh M, Radisky DC and
Bissell MJ: Mechanisms of disease: Epithelial-mesenchymal
transition - does cellular plasticity fuel neoplastic progression?
Nat Clin Pract Oncol. 5:280–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: Paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oue T, Yoneda A, Uehara S, Yamanaka H and
Fukuzawa M: Increased expression of the hedgehog signaling pathway
in pediatric solid malignancies. J Pediatr Surg. 45:387–392. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang C, Mei L, Pan L, Xiong W, Zhu H, Ruan
H, Zou C, Tang L, Iguchi T and Wu X: Hedgehog signaling through
GLI1 and GLI2 is required for epithelial-mesenchymal transition in
human trophoblasts. Biochim Biophys Acta. 1850:1438–1448. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Gu S, Huang J, Chen S, Zhang Z and
Xu M: Inhibition of autophagy potentiates the efficacy of Gli
inhibitor GANT-61 in MYCN-amplified neuroblastoma cells. BMC
Cancer. 14:7682014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jechlinger M, Grünert S and Beug H:
Mechanisms in epithelial plasticity and metastasis: Insights from
3D cultures and expression profiling. J Mammary Gland Biol
Neoplasia. 7:415–432. 2002. View Article : Google Scholar
|
|
16
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao
L, Li R, Zhao QD, Yang Y, Lu ZH, et al: Tumor-associated
macrophages promote cancer stem cell-like properties via
transforming growth factor-beta1-induced epithelial-mesenchymal
transition in hepatocellular carcinoma. Cancer Lett. 352:160–168.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao M, Kong L, Liu Y and Qu H: dbEMT: An
epithelial-mesenchymal transition associated gene resource. Sci
Rep. 5:114592015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jang MJ, Baek SH and Kim JH: UCH-L1
promotes cancer metastasis in prostate cancer cells through EMT
induction. Cancer Lett. 302:128–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Lamouille S and Derynck R:
TGF-β-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao B and Chen YG: Regulation of TGF-β
signal transduction. Scientifica (Cairo). 2014:8740652014.
|
|
22
|
Chen HN, Yuan K, Xie N, Wang K, Huang Z,
Chen Y, Dou Q, Wu M, Nice EC, Zhou ZG, et al: PDLIM1 stabilizes the
E-cadherin/β-catenin complex to prevent epithelial-mesenchymal
transition and metastatic potential of colorectal cancer cells.
Cancer Res. 76:1122–1134. 2016. View Article : Google Scholar
|
|
23
|
Kasai H, Allen JT, Mason RM, Kamimura T
and Zhang Z: TGF-β1 induces human alveolar epithelial to
mesenchymal cell transition (EMT). Respir Res. 6:562005. View Article : Google Scholar
|
|
24
|
Ellenrieder V, Hendler SF, Boeck W,
Seufferlein T, Menke A, Ruhland C, Adler G and Gress TM:
Transforming growth factor β1 treatment leads to an
epithelial-mesenchymal transdifferentiation of pancreatic cancer
cells requiring extracellular signal-regulated kinase 2 activation.
Cancer Res. 61:4222–4228. 2001.PubMed/NCBI
|
|
25
|
Rees JR, Onwuegbusi BA, Save VE, Alderson
D and Fitzgerald RC: In vivo and in vitro evidence for transforming
growth factor-β1-mediated epithelial to mesenchymal transition in
esophageal adenocarcinoma. Cancer Res. 66:9583–9590. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yap AS, Crampton MS and Hardin J: Making
and breaking contacts: the cellular biology of cadherin regulation.
Curr Opin Cell Biol. 5:508–514. 2007. View Article : Google Scholar
|
|
27
|
Yang G, Lu W, Yu D, Sun C, Guo J, Li Z and
Guan F: Quantitative analysis of differential proteome expression
in epithelial-to-mesenchymal transition of bladder epithelial cells
using SILAC method. Molecules. 21:842016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Derynck R, Muthusamy BP and Saeteurn KY:
Signaling pathway cooperation in TGF-β-induced
epithelial-mesenchymal transition. Curr Opin Cell Biol. 31:56–66.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fruman DA and Rommel C: PI3K and cancer:
Lessons, challenges and opportunities. Nat Rev Drug Discov.
13:140–156. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamouille S, Connolly E, Smyth JW, Akhurst
RJ and Derynck R: TGF-β-induced activation of mTOR complex 2 drives
epithelial-mesenchymal transition and cell invasion. J Cell Sci.
125:1259–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dennler S, André J, Alexaki I, Li A,
Magnaldo T, ten Dijke P, Wang XJ, Verrecchia F and Mauviel A:
Induction of sonic hedgehog mediators by transforming growth
factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression
in vitro and in vivo. Cancer Res. 67:6981–6986. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maitah MY, Ali S, Ahmad A, Gadgeel S and
Sarkar FH: Up-regulation of sonic hedgehog contributes to
TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells.
PLoS One. 6:e160682011. View Article : Google Scholar
|
|
33
|
Takebe N, Warren RQ and Ivy SP: Breast
cancer growth and metastasis: Interplay between cancer stem cells,
embryonic signaling pathways and epithelial-to-mesenchymal
transition. Breast Cancer Res. 13:2112011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Campbell V and Copland M: Hedgehog
signaling in cancer stem cells: A focus on hematological cancers.
Stem Cells Cloning. 8:27–38. 2015.PubMed/NCBI
|
|
35
|
Pandolfi S and Stecca B: Cooperative
integration between HEDGEHOG-GLI signalling and other oncogenic
pathways: Implications for cancer therapy. Expert Rev Mol Med.
17:e52015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin
JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, et al: Hedgehog/Gli
promotes epithelial-mesenchymal transition in lung squamous cell
carcinomas. J Exp Clin Cancer Res. 33:342014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choudhry Z, Rikani AA, Choudhry AM, Tariq
S, Zakaria F, Asghar MW, Sarfraz MK, Haider K, Shafiq AA and
Mobassarah NJ: Sonic hedgehog signalling pathway: A complex
network. Ann Neurosci. 21:28–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou J, Zhu G, Huang J, Li L, Du Y, Gao Y,
Wu D, Wang X, Hsieh JT, He D, et al: Non-canonical GLI1/2
activation by PI3K/AKT signaling in renal cell carcinoma: A novel
potential therapeutic target. Cancer Lett. 370:313–323. 2016.
View Article : Google Scholar
|
|
39
|
Souzaki R, Tajiri T, Souzaki M, Kinoshita
Y, Tanaka S, Kohashi K, Oda Y, Katano M and Taguchi T: Hedgehog
signaling pathway in neuroblastoma differentiation. J Pediatr Surg.
45:2299–2304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fan Q, Gu D, Liu H, Yang L, Zhang X, Yoder
MC, Kaplan MH and Xie J: Defective TGF-β signaling in bone
marrow-derived cells prevents hedgehog-induced skin tumors. Cancer
Res. 74:471–483. 2014. View Article : Google Scholar
|
